APA (7th ed.) Citation

VW, S., ME, L., CA, P., JJ, P., JD, S., Y, W., . . . JA, M. (2024). Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic. Journal of medicinal chemistry, 67(5), 3935. https://doi.org/10.1021/acs.jmedchem.3c02248

Chicago Style (17th ed.) Citation

VW, Shurtleff, et al. "Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic." Journal of Medicinal Chemistry 67, no. 5 (2024): 3935. https://doi.org/10.1021/acs.jmedchem.3c02248.

MLA (9th ed.) Citation

VW, Shurtleff, et al. "Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic." Journal of Medicinal Chemistry, vol. 67, no. 5, 2024, p. 3935, https://doi.org/10.1021/acs.jmedchem.3c02248.